A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma

BACKGROUNDS: PD-1 inhibitors and TKIs have been used to treat advanced osteosarcoma, but there is still a lack of intuitive data for the comparison of their efficacy. We conducted a meta-analysis to evaluate their therapeutic benefits. METHODS: A systematic methodological search of five primary elec...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Binhao, Chang, Junli, Sun, Xingyuan, Ma, Xiaoping, Zhao, Peng, Zhou, Chujie, Wang, Yongjun, Yang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291171/
https://www.ncbi.nlm.nih.gov/pubmed/37377920
http://dx.doi.org/10.3389/fonc.2023.1148735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291171/
https://www.ncbi.nlm.nih.gov/pubmed/37377920
http://dx.doi.org/10.3389/fonc.2023.1148735

Ejemplares similares